Clinical Trials Grant (osteosarcoma)

The Clinical Trials Grant from the Osteosarcoma Institute supports researchers worldwide planning to conduct clinical trials in osteosarcoma. The proposed trial may be conducted at a single institution, a clinical trial consortium, or through an existing clinical trial infrastructure. The results of the proposed trial should be expected within 3 years. Applicants may apply for up to 800,000 USD. Letters of intent are due on November 15, 2021. Invited full applications are due on April 14, 2022.

Challenge:

Letter of inquiry (LOI) closing date: 

November 15, 2021

Full-application closing date: 

April 14, 2022

Grant type:

Research Grant

Grant duration:

3 years

Grant amount:

800,000 USD

Recipient qualification:

Any doctoral degree

Recipient citizenship:

Global

Host location:

Global